NEVRO CORP (NVRO) Stock Analyst Ratings
USA - NYSE:NVRO - US64157F1030 - Common Stock
5.84 USD
0 (0%)
5.8401 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 54% to NVRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.87. This target is 51.87% above the current price.
NVRO was analyzed by 19 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about NVRO.
In the previous month the buy percentage consensus was at a similar level.
NVRO was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-07 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-07 | Piper Sandler | Upgrade | Underweight -> Neutral |
| 2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2024-12-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-12-09 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-12-03 | Wells Fargo | Reiterate | Equal-Weight |
| 2024-12-02 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2024-11-12 | JMP Securities | Reiterate | Market Perform |
| 2024-11-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-12 | Baird | Maintains | Neutral -> Neutral |
| 2024-11-12 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-11-12 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2024-10-01 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-08-09 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-08-08 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
| 2024-08-08 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-07 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-07 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2024-08-07 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-08-07 | Baird | Maintains | Neutral -> Neutral |
| 2024-08-07 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2024-07-16 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-10 | Citigroup | Maintains | Sell -> Sell |
| 2024-05-22 | Citigroup | Downgrade | Neutral -> Sell |
| 2024-05-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-08 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-05-08 | Piper Sandler | Maintains | Underweight -> Underweight |
NEVRO CORP / NVRO FAQ
Can you provide the average price target for NEVRO CORP stock?
19 analysts have analysed NVRO and the average price target is 8.87 USD. This implies a price increase of 51.87% is expected in the next year compared to the current price of 5.84.
How do analysts rate NEVRO CORP (NVRO)?
The consensus rating for NEVRO CORP (NVRO) is 53.6842 / 100 . This indicates that analysts generally have a neutral outlook on the stock.